No Data
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag
Castle Biosciences Price Target Maintained With a $41.00/Share by Stephens & Co.
Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock
Castle Biosciences Analyst Ratings
Lake Street Maintains Castle Biosciences(CSTL.US) With Buy Rating, Maintains Target Price $40
Analysts' Top Healthcare Picks: Lifecore Biomedical (LFCR), Castle Biosciences (CSTL)
loading...